This article was originally published as a bonus piece on November 20, but it appears that most of our readers missed it… and I continue to get tons of questions about it… so we’re re-posting it for you today. It has not been updated or revised since it was posted two weeks ago. I’ve gotten […]
Growth-oriented model portfolio subscription that aims to build a portfolio of “triple in 18 months” positions and trade around those positions along the way to goose returns (averaging up, adding options speculations, and selling options for income). Launched November 2020.
And lo, as the cannabis promoters try to ramp up interest in their sector again after a long dormancy, we are presented with yet another “secret” pot stock to sleuthify. The ad I’m looking at today is a teaser pitch from Don Yocham, Executive Director of the National Institute for Cannabis Investors (NICI), hosting an […]
Higher cost newsletter from pot investor Danny Brody, aims to identify both small and emerging cannabis companies and those that might “jump” to US exchanges for a higher profile.
Newsletters have taken to hiring spokespeople for their promo videos, trying to give them that extra flash of veritas and professionalism and a nice “anchor voice”, and this time it’s actress and former journalist Suzanne Sena that Money Morning brings in to pitch their “super vaccine” idea… which doesn’t mean anything about the stock, of […]
New high-end biotech service from Michael Robinson, who also edits the tech and biotech-focused Nexus-9 and Nova-X newsletters. Launched during the biotech boom caused by the COVID-19 pandemic, aims to produce a new recommendation every week, and focus on world-changing biotech innovations.
This is an “upgrade” service from the Money Map Press/National Institute of Cannabis Investors publishing group, promising “a brand-new research service dedicated to bringing average investors four to six private investment deals over the next 12 months,” things like lightly regulated Regulation A and “crowdfunding” deals as well as those restricted to accredited investors.